Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Clinical trial NCT02914561 · COMPLETED
Trial details
- NCT number
- NCT02914561
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-31
- Primary completion
- 2022-11-11
- Enrollment
- 1372
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.